Related Experiment Video
Updated: Jul 27, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
[Research Progress of Non-coding RNAs in the Regulation of Multiple Myeloma Bone Disease--Review]
Su-Mei Li1, Man-Ya Yu1, Xing Cui2
1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250011, Shandong Province, China.
Abstract:
Multiple myeloma bone disease is the most common complication of multiple myeloma, which mutually promotes the progression of multiple myeloma, severely affects patients' survival quality and prognosis. Recently, many studies revealed that non-coding RNAs play an important role in the imbalance of bone remodeling by regulating gene expression and participating in various signaling pathways. Additionally, most bone lesions fail to heal even when myeloma patients are in complete remission due to the sustained suppression of osteoblast activity, while non-coding RNAs may become a novel research field and clinical intervention targets. In this review, the latest research advances of non-coding RNAs which affect the occurrence and progress of multiple myeloma bone disease are summarized briefly.
Insights
Non-coding RNAs are key regulators of bone remodeling in multiple myeloma bone disease. Targeting these molecules offers a promising new avenue for treating persistent bone lesions in patients.
Area of Science:
- Oncology
- Molecular Biology
- Bone Biology
Background:
- Multiple myeloma bone disease is a frequent complication that worsens prognosis and quality of life.
- This bone disease involves an imbalance in bone remodeling, contributing to myeloma progression.
- Existing treatments often fail to heal bone lesions, even in remission, due to suppressed osteoblast activity.
Purpose of the Study:
- To review recent advances in understanding non-coding RNAs in multiple myeloma bone disease.
- To highlight the role of non-coding RNAs in regulating gene expression and signaling pathways involved in bone remodeling.
- To explore non-coding RNAs as potential therapeutic targets for multiple myeloma bone disease.
Main Methods:
- Literature review of recent studies on non-coding RNAs and multiple myeloma bone disease.
- Analysis of research on non-coding RNA regulation of gene expression in bone remodeling.
- Synthesis of findings on the role of non-coding RNAs in osteoblast activity and bone healing.
Main Results:
- Non-coding RNAs significantly influence the imbalance of bone remodeling in multiple myeloma.
- These molecules regulate critical genes and signaling pathways affecting bone metabolism.
- Non-coding RNAs are implicated in the failure of bone lesions to heal in myeloma patients.
Conclusions:
- Non-coding RNAs are crucial players in the pathogenesis of multiple myeloma bone disease.
- Dysregulation of non-coding RNAs contributes to impaired bone healing and osteoblast suppression.
- Non-coding RNAs represent a novel and promising field for therapeutic intervention in multiple myeloma bone disease.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
The Nucleolus
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Regulation of Expression at Multiple Steps